Krystal Biotech, Inc.

KRYS

—

Advanced chart & tools →

Krystal Biotech, Inc.KRYS

$0.00

+$0.00(+NaN%)Past Year

Jun 25Sep 25Dec 25Mar 26Jun 26

Key statistics

Market cap

—

P/E ratio

—

EPS (diluted)

$6.84

Dividend yield

0.00%

Dividend / share

$0.00

Revenue

$389.13M

Net income

$204.83M

Net margin

52.6%

Gross margin

—

Dividends & financials

Krystal Biotech, Inc. (KRYS) reported revenue of $389.13M and net income of $204.83M, or $6.84 per diluted share. It does not currently pay a dividend. Financial figures are sourced from the company’s latest public filings; the price chart updates live, 24/7, even when the underlying market is closed.